InvestorsHub Logo
Followers 27
Posts 744
Boards Moderated 0
Alias Born 07/12/2012

Re: exwannabe post# 268928

Monday, 07/25/2016 9:08:47 AM

Monday, July 25, 2016 9:08:47 AM

Post# of 345950
OK, Ex, did you actually read the studies you posted

None of them uses adjuvant hormonal therapy in combination with downstream 1.0 inhibitors.

Not one.

Yes, there is one study with HER2+ positive receptor breast cancer, but no mention of Herceptin (which is a limited field anyway as only 20% of breast cancers express this gene receptor.)

Ditto for all the others. No tamoxifen, no Xtandi. No Herceptin.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News